A detailed history of New York State Common Retirement Fund transactions in Neuro Pace Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 900 shares of NPCE stock, worth $10,773. This represents 0.0% of its overall portfolio holdings.

Number of Shares
900
Previous 14,300 93.71%
Holding current value
$10,773
Previous $108,000 94.44%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$6.65 - $8.46 $89,110 - $113,364
-13,400 Reduced 93.71%
900 $6,000
Q2 2024

Jul 31, 2024

BUY
$6.38 - $15.33 $91,234 - $219,219
14,300 New
14,300 $108,000
Q2 2022

Aug 04, 2022

SELL
$4.95 - $8.7 $29,700 - $52,199
-6,000 Reduced 98.91%
66 $0
Q3 2021

Nov 02, 2021

BUY
$15.85 - $25.07 $1,046 - $1,654
66 Added 1.1%
6,066 $96,000
Q2 2021

Aug 02, 2021

BUY
$19.03 - $26.5 $114,180 - $159,000
6,000 New
6,000 $143,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $297M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.